STEAP1 and neoplasm: To conclude, data presented in this study demonstrate that ChAdOx1–MVA-based vaccination strategy targeting prostate-associated antigen STEAP1 is able to elicit strong sustained STEAP1-specific immunity in mice and confers partial tumour protection in transplantable and spontaneous PCa mouse models.